Lycium barbarum glycopeptide mitigates retinal ischemia-reperfusion injury through its anti-inflammatory, anti- senescence, and anti-apoptosis properties

Abstract This study investigates the therapeutic potential of lycium barbarum glycopeptide (LbGp) in mitigating retinal ischemia-reperfusion injury (RIRI), a key pathological mechanism in glaucoma. RIRI involves inflammation, cellular senescence, and apoptosis, leading to retinal ganglion cell (RGC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunlin Zhao, Xuejing Lu, Yanxia Zhao, Wei Shi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10763-y
Tags: Add Tag
No Tags, Be the first to tag this record!